Long-term outcomes of patients with apical hypertrophic cardiomyopathy: incorporation of a novel risk score.

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Milind Desai

Cleveland Clinic, Cleveland (United States of America)

5 More presentations in this session

Presentation thumbnail

Identification and validation of ventricular rhythmic risk subgroups in hypertrophic cardiomyopathy by clustering analysis including left ventricular strain analysis

Doctor A. Al wazzan (Rennes, FR)

Abstract Slides Video

Presentation thumbnail

Automated deep learning approach for identifying etiologies of hypertrophic phenocopies by echocardiography

Mr P. Su (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

Artificial intelligence-guided screening of under-recognized cardiomyopathies adapted for point-of-care echocardiography

Doctor E. Oikonomou (New Haven, US)

Abstract Slides Video

Presentation thumbnail

Extra cellular volume by computed tomography is useful for prediction of prognosis in cardiac sarcoidosis

Doctor Y. Nishikawa (Chiba, JP)

Abstract Slides Video

Presentation thumbnail

Arrhythmogenic right ventricular cardiomyopathy: the importance of biventricular strain in risk-stratification

Doctor A. Chua (Leiden, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Imaging to improve diagnosis and risk-stratification of cardiomyopathies

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Echocardiography as first-line technique in suspected cardiac amyloidosis

Congress Presentation

What is the best imaging method to assess myocardial viability? 

Congress Presentation

Dilated cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources